Influence of the preimplantation QRS axis on responses to cardiac resynchronization therapy;Influencia del eje eléctrico QRS preimplante en la respuesta a la terapia de resincronización cardiaca

Revista Espanola de Cardiologia

Volumn 61, Issue 12, 2008, Pages 1245-1252

  García Seara, F Javier ^a,b   Martínez Sande, José L ^a   Cid, Belén ^a   Gude, Francisco ^a   Bastos, María ^a   Domínguez, Miguel ^a   Varela, Alfonso ^a   González Juanatey, José R ^a  

^a Instituto de Salud Carlos III   (Spain)

^b NONE   (Spain)

Author keywords

Biventricular pacing; Cardiac resynchronization; Coronary veins; Electrocardiogram; Heart failure

Indexed keywords

AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; QRS COMPLEX; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 57349094461     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/s0300-8932(08)75731-2     Document Type: Article

References (32)

1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite ventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al; for the MIRACLE Study Group. Multicenter inSync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
3. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. The PAcing THerapies for Congestive Heart Failure (PATHCHF) study: rationales, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol. 1999;83:130-5.
4. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 2003;289:2685-94.
5. Bristow LR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac resynchronization therapy with or without an implantable desfibrillator in advanced chronic heart failure. The comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) investigators. N Engl J Med. 2004;350:2140-50.
6. Cleland GJ, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. For the cardiac resynchronization heart failure investigators. N Engl J Med. 2005;352:1539-49.
7. Díaz-Infante E, Berruezo A, Mont L, Osorio P, García- Morán E, Marigliano A, et al. Predictores de ausencia de mejoría clínica a medio plazo con la terapia de resincronización cardiaca. Rev Esp Cardiol. 2004;57:306-12.
8. Yeim S, Bordachar P, Reuter S, Laborderie J, O'Neill M, Lafitte S, et al. Predictors of a positive reponse to biventricular pacing in patients with severe heart failure and ventricular conduction delay. Pacing Clin Electrophysiol. 2007;30:970-5.
9. Richardson M, Freemantle N, Calvert M, Cleland J, Tavazzi L. Predictors and treatment reponse with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis fron the CARE-HF trial. Eur J Cardiol. 2007;28:1827-34.
10. Pires L, Abraham W, Young J, Johnson K, the MIRACLE investigators. Clinical predictors and timing of NYHA class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the multicenter InSync randomized clinical evaluation (MIRACLE) and multicenter InSync ICD randomized clinical evaluation (MIRACLE-ICD) trials. Am Heart J. 2006;151:837-53.
11. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, et al. Tissue doppler imaging predicts improved systolic performance and reversed left ventricular remodelling during long-term cardiac resynchronization therapy. J Am Coll Cardiol. 2002;40:1615-22.
12. Yu CM, Abraham W, Bax J, Chung E, Fedewa M, Ghio S, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT) study design. Am Heart J. 2005;149:600-5.
13. Cleland JG, Abdellah AT, Khaleva O, Coletta AP. Clark AL. Clinical trials update from the European Society of Cardiology Congress 2007. 3CPO, ALOFT, PROSPECT and statins for heart failure. Eur J Heart Fail. 2007;9:1070-3.
14. Vasallo JA, Cassidy DM, Miller JM, Buxton AE, Marchinskly FE, Josephson ME. Left ventricular endocardial activation during right ventricular pacing. Effect of underlying heart disease. J Am Coll Cardiol. 1986;7:1228-33.
15. Achilli A, Peraldo C, Sassara M, Orazi S, Bianchi S, Laurenzi F, et al. Prediction of response to cardiac resynchronization therapy: The selection of candidates for CRT (SCART) study. Pacing Clin Electrophysiol. 2006;29:S11-9.
16. Reynolds M, Joventino L, Josephson M. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure. Pacing Clin Electrophysiol. 2004;27:1513-8.
17. Bleeker GB, Kaandorp PA, Lamb HJ, Boersma E, Steendij P, De Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969-76.
18. Butter C, Auricchio A, Stellbrik C, Fleck E, Ding J, Yu Y, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation. 2001;104:3026-9.
19. Albertesen A, Nielsen J, Pedersen A, Hansen P, Jensen H, Mortensen P. Left ventricular lead performance in cardiac resynchronization therapy: Impact of lead location and complications. Pacing Clin Electrophysiol. 2005;28:483-8.
20. Reuter S, Garrigue S, Barold S, Jais P, Hocini M, Haissaguerre M, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol. 2002;89:346-50.
21. Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, De Place C, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J. 2005;26:1094-100.
22. Yu C, Bleeker G, Wing-Hong Fung J, Schalij M, Zhang Q, Van der Wall E, et al. Left ventricular reverse remodelling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112:1580-6.
23. Bax JJ, Bleeker GB, Marwichk TH, Molhoek S, Boersma E, Steendkijk P, et al. Left ventrticular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-40.
24. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier A, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-16.
25. Alonso C, Leclercq C, Victor F, Hassan D, Mansour H, De Place C, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advance heart failure. Am J Cardiol. 1999;84:1417-21.
26. Ricci R, Pignalberi C, Ansalone G, Jannone E, Vaccaro MV, Denaro A, et al. Early and late QRS morphology and width in biventricular pacing: Relationship to lead site and electrical remodelling. J Interv Card Electrophysiol. 2002;6:279-82.
27. Vidal B, Sitges M, Delgado V, Mont L, Díaz-Infante E, Azqueta M, et al. Influencia de la cardiopatía subyacente en la respuesta a la terapia de resincronización cardiaca. Rev Esp Cardiol. 2007;60:1264-71.
28. Lellouche N, De Diego C, Cesario DA, Vaseghi M, Horowitz BN, Mahajan A, et al. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:242-6.
29. Henrikson CA, Spragg DD, Cheng A, Capps M, Devaughn K, Marine JE, et al. Evidence for electrical remodelling of the native conduction system with cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2007;30:587-90.
30. Mollema SA, Bleeker GB, Van de Wall EE, Schalij MJ, Bax JJ. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol. 2007;100:1665-70.
31. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol. 2003;42:2117-24.
32. Lenarczyk R, Kowalsky O, Pruszkowska-Skrzep P, Kukulsi T, Pluta S, Szulik M, et al. Triple site biventricular pacing in a patient with congestive heart failure and severe mechanical dyssynchrony. J Interv Card Electrophysiol. 2007;18:187-90.